168 related articles for article (PubMed ID: 15764169)
1. In vitro inhibition of SARS virus replication by human interferons.
Dahl H; Linde A; Strannegård O
Scand J Infect Dis; 2004; 36(11-12):829-31. PubMed ID: 15764169
[TBL] [Abstract][Full Text] [Related]
2. Potent in vitro activity of the albumin fusion type 1 interferons (albumin-interferon-alpha and albumin-interferon-beta) against RNA viral agents of bioterrorism and the severe acute respiratory syndrome (SARS) virus.
Subramanian GM; Moore PA; Gowen BB; Olsen AL; Barnard DL; Paragas J; Hogan RJ; Sidwell RW
Chemotherapy; 2008; 54(3):176-80. PubMed ID: 18560223
[TBL] [Abstract][Full Text] [Related]
3. Interferon-beta 1a and SARS coronavirus replication.
Hensley LE; Fritz LE; Jahrling PB; Karp CL; Huggins JW; Geisbert TW
Emerg Infect Dis; 2004 Feb; 10(2):317-9. PubMed ID: 15030704
[TBL] [Abstract][Full Text] [Related]
4. Interferon-beta and interferon-gamma synergistically inhibit the replication of severe acute respiratory syndrome-associated coronavirus (SARS-CoV).
Sainz B; Mossel EC; Peters CJ; Garry RF
Virology; 2004 Nov; 329(1):11-7. PubMed ID: 15476870
[TBL] [Abstract][Full Text] [Related]
5. Type I Interferon Susceptibility Distinguishes SARS-CoV-2 from SARS-CoV.
Lokugamage KG; Hage A; de Vries M; Valero-Jimenez AM; Schindewolf C; Dittmann M; Rajsbaum R; Menachery VD
J Virol; 2020 Nov; 94(23):. PubMed ID: 32938761
[TBL] [Abstract][Full Text] [Related]
6. Ribavirin and interferon-beta synergistically inhibit SARS-associated coronavirus replication in animal and human cell lines.
Morgenstern B; Michaelis M; Baer PC; Doerr HW; Cinatl J
Biochem Biophys Res Commun; 2005 Jan; 326(4):905-8. PubMed ID: 15607755
[TBL] [Abstract][Full Text] [Related]
7. The antiviral effect of interferon-beta against SARS-coronavirus is not mediated by MxA protein.
Spiegel M; Pichlmair A; Mühlberger E; Haller O; Weber F
J Clin Virol; 2004 Jul; 30(3):211-3. PubMed ID: 15135736
[TBL] [Abstract][Full Text] [Related]
8. Increased sensitivity of SARS-coronavirus to a combination of human type I and type II interferons.
Scagnolari C; Vicenzi E; Bellomi F; Stillitano MG; Pinna D; Poli G; Clementi M; Dianzani F; Antonelli G
Antivir Ther; 2004 Dec; 9(6):1003-11. PubMed ID: 15651759
[TBL] [Abstract][Full Text] [Related]
9. The synergistic interaction of interferon types I and II leads to marked reduction in severe acute respiratory syndrome-associated coronavirus replication and increase in the expression of mRNAs for interferon-induced proteins.
Scagnolari C; Trombetti S; Alberelli A; Cicetti S; Bellarosa D; Longo R; Spanò A; Riva E; Clementi M; Antonelli G
Intervirology; 2007; 50(2):156-60. PubMed ID: 17191018
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of SARS-CoV-2 by type I and type III interferons.
Felgenhauer U; Schoen A; Gad HH; Hartmann R; Schaubmar AR; Failing K; Drosten C; Weber F
J Biol Chem; 2020 Oct; 295(41):13958-13964. PubMed ID: 32587093
[TBL] [Abstract][Full Text] [Related]
11. Severe acute respiratory syndrome-related coronavirus is inhibited by interferon- alpha.
Ströher U; DiCaro A; Li Y; Strong JE; Aoki F; Plummer F; Jones SM; Feldmann H
J Infect Dis; 2004 Apr; 189(7):1164-7. PubMed ID: 15031783
[TBL] [Abstract][Full Text] [Related]
12. Antiviral activities of type I interferons to SARS-CoV-2 infection.
Mantlo E; Bukreyeva N; Maruyama J; Paessler S; Huang C
Antiviral Res; 2020 Jul; 179():104811. PubMed ID: 32360182
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of immunomodulators, interferons and known in vitro SARS-coV inhibitors for inhibition of SARS-coV replication in BALB/c mice.
Barnard DL; Day CW; Bailey K; Heiner M; Montgomery R; Lauridsen L; Chan PK; Sidwell RW
Antivir Chem Chemother; 2006; 17(5):275-84. PubMed ID: 17176632
[TBL] [Abstract][Full Text] [Related]
14. [Present state of in vitro and in vivo studies on efficacy of medical nonspecific protective agents with respect to genotype IV coronavirus causing severe acute respiratory syndrome].
Shchukina VN; Loginova SIa; Borisevich SV; Bondarev VP
Antibiot Khimioter; 2011; 56(9-10):41-6. PubMed ID: 22586904
[TBL] [Abstract][Full Text] [Related]
15. Antiviral Activity of Type I, II, and III Interferons Counterbalances ACE2 Inducibility and Restricts SARS-CoV-2.
Busnadiego I; Fernbach S; Pohl MO; Karakus U; Huber M; Trkola A; Stertz S; Hale BG
mBio; 2020 Sep; 11(5):. PubMed ID: 32913009
[TBL] [Abstract][Full Text] [Related]
16. Interferon-gamma and interleukin-4 downregulate expression of the SARS coronavirus receptor ACE2 in Vero E6 cells.
de Lang A; Osterhaus AD; Haagmans BL
Virology; 2006 Sep; 353(2):474-81. PubMed ID: 16860835
[TBL] [Abstract][Full Text] [Related]
17. [Development of the cDNA chip for SARS virus and a primary study on the possible molecular mechanism of interferon alpha2b inhibiting the SARS virus replication].
Shu YL; Duan ZJ; Wang Z; Sun MS; Zhang J; Zhang LL; Ma XJ; Peng JP; Jin Q; Hou YD
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2003 Sep; 17(3):209-12. PubMed ID: 15340559
[TBL] [Abstract][Full Text] [Related]
18. Comparative analysis of anti-hepatitis C virus activity and gene expression mediated by alpha, beta, and gamma interferons.
Cheney IW; Lai VC; Zhong W; Brodhag T; Dempsey S; Lim C; Hong Z; Lau JY; Tam RC
J Virol; 2002 Nov; 76(21):11148-54. PubMed ID: 12368359
[TBL] [Abstract][Full Text] [Related]
19. Indomethacin has a potent antiviral activity against SARS coronavirus.
Amici C; Di Caro A; Ciucci A; Chiappa L; Castilletti C; Martella V; Decaro N; Buonavoglia C; Capobianchi MR; Santoro MG
Antivir Ther; 2006; 11(8):1021-30. PubMed ID: 17302372
[TBL] [Abstract][Full Text] [Related]
20. [Preventive and therapeutic effects of recombinant IFN-alpha2b nasal spray on SARS-CoV infection in Macaca mulata].
Gao H; Zhang LL; Wei Q; Duan ZJ; Tu XM; Yu ZA; Deng W; Zhang LP; Bao LL; Zhang B; Tong W; Hou YD; Zhang BL; Huang L; Qin C
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2005 Sep; 19(3):207-10. PubMed ID: 16261198
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
